Skip to main content
. 2015 May 6;15:360. doi: 10.1186/s12885-015-1383-x

Figure 5.

Figure 5

CTCs from a triple negative breast cancer patient. Blood was processed and scanned as described and after identification with the CyteMapper® software representative cells were re-imaged at 40X using the CyteFinder® Scanner. (A) CTC from a triple negative breast cancer patient stained with antibodies to cytokeratin (green), Ki67 (red) and DAPI (blue). Cell appears bi-nucleate, or may be near the end of cell division. (B) Same CTC shown in A, but with only Ki67 antibody staining in red. (C, D) Cluster of many CTCs with heterogeneous EpCAM (red) and cytokeratin (green) expression. DAPI was used to stain nuclei.